Not admitted · Third-party claim
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 10 Mar 2025 · owen-1647
Quote
Third-party claim
“Respondents are most likely to offer psilocybin to patients if it is FDA approved (60 percent), followed by ketamine (50 percent) and MDMA (40 percent).”
Additional finding in the press release: which psychedelic therapies providers would offer if FDA approved; the release notes only ketamine is currently FDA approved.
A quoted or paraphrased claim by someone else that the author does not adopt as their own.